DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 300 participants.
Also called NCT05701917
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 300 participants
- Sponsor
- Registry
-
NCT05701917
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Austria, Finland, Germany, Switzerland, United Kingdom
- Registry status
- Recruiting
Technical summary
Registry record NCT05701917. Randomized; no masking; primary purpose treatment. Start 2023-01-06 (actual); primary completion 2028-01-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis
- Acronym
- DEFIANCE
- Condition
- Venous Thromboembolism
- Condition
- Deep Venous Thrombosis
- Condition
- Post-Thrombotic Syndrome
- Intervention (Device)
- ClotTriever System
- Intervention (Drug)
- Commercially available/market approved anticoagulation medication including but not limited to: Heparin Sodium, Coumadin, Rivaroxaban, Apixaban, etc.
- Lead sponsor
- Inari Medical
Record details
- Record id
cardio:ct-nct05701917- Content hash
ea47123c1e7c61e504672c8352dcffcf33c28adffda0deec0c72d57bc33bd7df